Simplex Trading’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,580
Closed -$10K 9939
2024
Q2
$10K Sell
1,580
-140
-8% -$952 ﹤0.01% 7471
2024
Q1
$18K Sell
1,720
-18,740
-92% -$203K ﹤0.01% 7195
2023
Q4
$12K Buy
20,460
+400
+2% +$6.48K ﹤0.01% 7335
2023
Q3
$435K Buy
20,060
+60
+0.3% +$1.92K ﹤0.01% 3555
2023
Q2
$770K Buy
20,000
+210
+1% +$7.41K ﹤0.01% 2856
2023
Q1
$548K Buy
19,790
+18,326
+1,252% +$621K ﹤0.01% 3168
2022
Q4
$48K Sell
1,464
-183
-11% -$13.3K ﹤0.01% 5950
2022
Q3
$199K Sell
1,647
-921
-36% -$166K ﹤0.01% 4618
2022
Q2
$449K Sell
2,568
-1,756
-41% -$370K ﹤0.01% 3570
2022
Q1
$1.25M Buy
4,324
+1,201
+38% +$456K ﹤0.01% 2632
2021
Q4
$1.63M Buy
3,123
+2,839
+1,000% +$2.04M ﹤0.01% 2261
2021
Q3
$241K Buy
284
+16
+6% +$6.86K ﹤0.01% 5311
2021
Q2
$239K Buy
268
+267
+26,700% +$204K ﹤0.01% 5394
2021
Q1
$88K Buy
+1
New +$1.38K ﹤0.01% 5926

Other funds holding BIOR

Simplex Trading's BIOR Position: Q3 2023 in Review

Simplex Trading sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q3 2023, closing a stake of 583 shares — an estimated $18.7K sold.

Simplex Trading first reported a position in BIOR in Q1 2021 and held it in 5 quarters. The position peaked at $22K in Q2 2023. 24 funds tracked by Wall St. Rank hold BIOR as of Q3 2023.

  • Simplex Trading reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Simplex Trading sold 583 Biora Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $18.7K.
  • Simplex Trading first reported a position in Biora Therapeutics, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Simplex Trading's Biora Therapeutics, Inc. Common Stock position peaked at $22K in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.